Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'RESISTANT DEPRESSION' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 150 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Dannon, PN; Grunhaus, L
      Effect of electroconvulsive therapy in repetitive transcranial magnetic stimulation non-responder MDD patients: a preliminary study

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    2. Wassermann, EM; Lisanby, SH
      Therapeutic application of repetitive transcranial magnetic stimulation: areview

      CLINICAL NEUROPHYSIOLOGY
    3. Sonawalla, SB; Fava, M
      Severe depression - Is there a best approach?

      CNS DRUGS
    4. Manes, F; Jorge, R; Morcuende, M; Yamada, T; Paradiso, S; Robinson, RG
      A controlled study of repetitive transcranial magnetic stimulation as a treatment of depression in the elderly

      INTERNATIONAL PSYCHOGERIATRICS
    5. Chae, JH; Nahas, Z; Li, XB; George, MS
      Transcranial magnetic stimulation in psychiatry: research and therapeutic applications

      INTERNATIONAL REVIEW OF PSYCHIATRY
    6. Catafau, AM; Perez, V; Gironell, A; Martin, JC; Kulisevsky, J; Estorch, M; Carrio, I; Alvarez, E
      SPECT mapping of cerebral activity changes induced by repetitive transcranial magnetic stimulation in depressed patients. A pilot study

      PSYCHIATRY RESEARCH-NEUROIMAGING
    7. Sackeim, HA; Rush, AJ; George, MS; Marangell, LB; Husain, MM; Nahas, Z; Johnson, CR; Seidman, S; Giller, C; Haines, S; Simpson, RK; Goodman, RR
      Vagus nerve stimulation (VNS (TM)) for treatment-resistant depression: Efficacy, side effects, and predictors of outcome

      NEUROPSYCHOPHARMACOLOGY
    8. Turcotte, JE; Debonnel, G; de Montigny, C; Hebert, C; Blier, P
      Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects

      NEUROPSYCHOPHARMACOLOGY
    9. Reneric, JP; Bouvard, M; Stinus, L
      Idazoxan and 8-OH-DPAT modify the behavioral effects induced by either NA,or 5-HT, or dual NA/5-HT reuptake inhibition in the rat forced swimming test

      NEUROPSYCHOPHARMACOLOGY
    10. Mulsant, BH; Alexopoulos, GS; Reynolds, CF; Katz, IR; Abrams, R; Oslin, D; Schulberg, HC
      Pharmacological treatment of depression in older primary care patients: the PROSPECT algorithm

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    11. Fahy, S; Lawlor, BA
      Discontinuation of lithium augmentation in an elderly cohort

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    12. Nemets, B; Fux, M; Levine, J; Belmaker, RH
      Combination of antidepressant drugs: The case of inositol

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    13. Hasey, G
      Transcranial magnetic stimulation in the treatment of mood disorder: A review and comparison with electroconvulsive therapy

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    14. McManus, P; Mant, A; Mitchell, P; Birkett, D; Dudley, J
      Co-prescribing of SSRIs and TCAs in Australia: how often does it occur andwho is doing it?

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    15. Hilleret, H; Jeunet, E; Osiek, C; Mohr, S; Blois, R; Bertschy, G
      Mania resulting from continuous positive airways pressure in a depressed man with sleep apnea syndrome

      NEUROPSYCHOBIOLOGY
    16. Zullino, D; Baumann, P
      Lithium augmentation in depressive patients not responding to selective serotonin reuptake inhibitors

      PHARMACOPSYCHIATRY
    17. Bschor, T; Canata, B; Muller-Oerlinghausen, B; Bauer, M
      Predictors of response to lithium augmentation in tricyclic antidepressant-resistant depression

      JOURNAL OF AFFECTIVE DISORDERS
    18. Sharma, V
      Loss of response to antidepressants and subsequent refractoriness: diagnostic issues in a retrospective case series

      JOURNAL OF AFFECTIVE DISORDERS
    19. Amsterdam, JD; Chopra, M
      Monoamine oxidase inhibitors revisited

      PSYCHIATRIC ANNALS
    20. McNamara, B; Ray, JL; Arthurs, OJ; Boniface, S
      Transcranial magnetic stimulation for depression and other psychiatric disorders

      PSYCHOLOGICAL MEDICINE
    21. Smesny, S; Volz, HP; Liepert, J; Tauber, R; Hochstetter, A; Sauer, H
      Reptitive transcranial magnetic stimulation (rTMS) in acute and long-term treatment of therapy-resistant depression - a case report

      NERVENARZT
    22. Gnerre, C; Kosel, M; Baumann, P; Carrupt, PA; Testa, B
      Interaction of psychotropic drugs with monoamine oxidase in rat brain

      JOURNAL OF PHARMACY AND PHARMACOLOGY
    23. Cohrs, S; Tergau, F; Korn, J; Becker, W; Hajak, G
      Suprathreshold repetitive transcranial magnetic stimulation elevates thyroid-stimulating hormone in healthy male subjects

      JOURNAL OF NERVOUS AND MENTAL DISEASE
    24. Chehil, S; Devarajan, S; Dursun, SM
      Just the berries - Pharmacologic management of refractory depression

      CANADIAN FAMILY PHYSICIAN
    25. Nahas, Z; Lomarev, M; Roberts, DR; Shastri, A; Lorberbaum, JP; Teneback, C; McConnell, K; Vincent, DJ; Li, XB; George, MS; Bohning, DE
      Unilateral left prefrontal transcranial magnetic stimulation (TMS) produces intensity-dependent bilateral effects as measured by interleaved BOLD fMRI

      BIOLOGICAL PSYCHIATRY
    26. Orth, DN; Shelton, RC; Nicholson, WE; Beck-Peccoz, P; Tomarken, AJ; Persani, L; Loosen, PT
      Serum thyrotropin concentrations and bioactivity during sleep deprivation in depression

      ARCHIVES OF GENERAL PSYCHIATRY
    27. Dursun, SM; Devarajan, S
      Reboxetine plus citalopram for refractory depression not responding to venlafaxine: possible mechanisms

      PSYCHOPHARMACOLOGY
    28. Shiah, IS; Yatham, LN
      Serotonin in mania and in the mechanism of action of mood stabilizers: a review of clinical studies

      BIPOLAR DISORDERS
    29. Chengappa, KNR; Levine, J; Gershon, S; Mallinger, AG; Hardan, A; Vagnucci, A; Pollock, B; Luther, J; Buttenfield, J; Verfaille, S; Kupfer, DJ
      Inositol as an add-on treatment for bipolar depression

      BIPOLAR DISORDERS
    30. Lisanby, SH; Datto, CJ; Szuba, MP
      ECT and TMS: Past, present, and future

      DEPRESSION AND ANXIETY
    31. Pridmore, S
      Substitution of rapid transcranial magnetic stimulation treatments for electroconvulsive therapy treatments in a course of electroconvulsive therapy

      DEPRESSION AND ANXIETY
    32. Lisanby, SH; Belmaker, RH
      Animal models of the mechanisms of action of repetitive transcranial magnetic stimulation (rTMS): Comparisons with electroconvulsive shock (ECS)

      DEPRESSION AND ANXIETY
    33. Pellegrino, TC; Bayer, BM
      Specific serotonin reuptake inhibitor-induced decreases in lymphocyte activity require endogenous serotonin release

      NEUROIMMUNOMODULATION
    34. Keck, ME; Sillaber, I; Ebner, K; Welt, T; Toschi, N; Kaehler, ST; Singewald, N; Philippu, A; Elbel, GK; Wotjak, CT; Holsboer, F; Landgraf, R; Engelmann, M
      Acute transcranial magnetic stimulation of frontal brain regions selectively modulates the release of vasopressin, biogenic amines and amino acids inthe rat brain

      EUROPEAN JOURNAL OF NEUROSCIENCE
    35. Cohen, H; Benjamin, J; Kaplan, Z; Kotler, M
      Administration of high-dose ketoconazole, an inhibitor of steroid synthesis, prevents posttraumatic anxiety in an animal model

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    36. Mischoulon, D; Nierenberg, AA; Kizilbash, L; Rosenbaum, JF; Fava, M
      Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: A survey of clinicians

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    37. Post, RM; Speer, AM; Weiss, SRB; Li, H
      Seizure models: Anticonvulsant effects of ECT and rTMS

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    38. Malhi, GS; Bartlett, JR
      Depression: a role for neurosurgery?

      BRITISH JOURNAL OF NEUROSURGERY
    39. Hawley, CJ; Loughlin, PJ; Quick, SJ; Gale, TM; Sivakumaran, T; Hayes, J; McPhee, S
      Efficacy, safety and tolerability of combined administration of lithium and selective serotonin reuptake inhibitors: a review of the current evidence

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    40. Dording, CM
      Antidepressant augmentation and combinations

      PSYCHIATRIC CLINICS OF NORTH AMERICA
    41. Izumi, T; Inoue, T; Kitagawa, N; Nishi, N; Shimanaka, S; Takahashi, Y; Kusumi, I; Odagaki, Y; Denda, K; Ohmori, T; Koyama, T
      Open pergolide treatment of tricyclic and heterocyclic antidepressant-resistant depression

      JOURNAL OF AFFECTIVE DISORDERS
    42. Montgomery, SA; Schatzberg, AF; Guelfi, JD; Kasper, S; Nemeroff, C; Swann, A; Zajecka, J
      Pharmacotherapy of depression and mixed states in bipolar disorder

      JOURNAL OF AFFECTIVE DISORDERS
    43. Fredman, SJ; Fava, M; Kienke, AS; White, CN; Nierenberg, AA; Rosenbaum, JF
      Partial response, nonresponse, and relapse with selective serotonin reuptake inhibitors in major depression: A survey of current "next-step" practices

      JOURNAL OF CLINICAL PSYCHIATRY
    44. Nelson, JC
      Augmentation strategies in depression 2000

      JOURNAL OF CLINICAL PSYCHIATRY
    45. Fava, M
      New approaches to the treatment of refractory depression

      JOURNAL OF CLINICAL PSYCHIATRY
    46. Marangell, LB
      Augmentation of standard depression therapy

      CLINICAL THERAPEUTICS
    47. Beique, JC; de Montigny, C; Blier, P; Debonnel, G
      Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. In vivo electrophysiological studies in the rat

      NEUROPHARMACOLOGY
    48. Pridmore, S; Oberoi, G
      Transcranial magnetic stimulation applications and potential use in chronic pain: studies in waiting

      JOURNAL OF THE NEUROLOGICAL SCIENCES
    49. Thase, ME; Sachs, GS
      Bipolar depression: Pharmacotherapy and related therapeutic strategies

      BIOLOGICAL PSYCHIATRY
    50. David, MM; Owen, JA; Abraham, G; Delva, NJ; Southmayd, SE; Wooltorton, E; Lawson, JS
      Thyroid function and response to 48-hour sleep deprivation in treatment-resistant depressed patients

      BIOLOGICAL PSYCHIATRY
    51. George, MS; Nahas, Z; Molloy, M; Speer, AM; Oliver, NC; Li, XB; Arana, GW; Risch, SC; Ballenger, JC
      A controlled trial of daily left prefrontal cortex TMS for treating depression

      BIOLOGICAL PSYCHIATRY
    52. Rush, AJ; George, MS; Sackeim, HA; Marangell, LB; Husain, MM; Giller, C; Nahas, Z; Haines, S; Simpson, RK; Goodman, R
      Vagus nerve stimulation (VNS) for treatment-resistant depressions: A multicenter study

      BIOLOGICAL PSYCHIATRY
    53. Montagnon, F; Said, S; Payan, C; Corruble, E; Taleb, M; Rouillon, F
      Clinical and epidemiological study of patients hospitalized for major depressive episode

      ANNALES MEDICO-PSYCHOLOGIQUES
    54. Bauer, M; Bschor, T; Kunz, D; Berghofer, A; Strohle, A; Muller-Oerlinghausen, B
      Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression

      AMERICAN JOURNAL OF PSYCHIATRY
    55. Karasu, TB; Gelenberg, A; Wang, P; Merriam, A; McIntyre, JS; Charles, SC; Zarin, DA; Altshuler, K; Tasman, A; Cook, I; Twemlow, S; Cross, CD; Woods, S; Egger, H; Yager, J; Moench, LA; Bittker, T; Peele, R; Clayton, P; Stabinsky, S; Das, A; Johnston, R; Flynn, L; Nininger, J; Goin, M; Urbaitis, J; Goldstein, M; D'Agostino, A; Gray, SH; Berg, J; Meltzer, H; Lurie, L; Norquist, G; Walker, RD; Davis, LS; Thaler, RM; Marcus, PB
      Practice guideline for the treatment of patients with major depressive disorder (revision)

      AMERICAN JOURNAL OF PSYCHIATRY
    56. Oyefeso, A; Valmana, A; Clancy, C; Ghodse, H; Williams, H
      Fatal antidepressant overdose among drug abusers and non-drug abusers

      ACTA PSYCHIATRICA SCANDINAVICA
    57. Corruble, E; Guelfi, JD
      Does increasing dose improve efficacy in patients with poor antidepressantresponse: a review

      ACTA PSYCHIATRICA SCANDINAVICA
    58. Humble, M
      Noradrenaline and serotonin reuptake inhibition as clinical principles: a review of antidepressant efficacy

      ACTA PSYCHIATRICA SCANDINAVICA
    59. Leucht, S; Hackl, HJ; Steimer, W; Angersbach, D; Zimmer, R
      Effect of adjunctive paroxetine on serum levels and side-effects of tricyclic antidepressants in depressive inpatients

      PSYCHOPHARMACOLOGY
    60. Mischoulon, D; Fava, M; Rosenbaum, JF
      Strategies for augmentation of SSRI treatment: A survey of an academic psychopharmacology practice

      HARVARD REVIEW OF PSYCHIATRY
    61. Horrobin, DF; Bennett, CN
      Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis - Possible candidate genes

      PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
    62. Souery, D; Amsterdam, J; de Montigny, C; Lecrubier, Y; Montgomery, S; Lipp, O; Racagni, G; Zohar, J; Mendlewicz, J
      Treatment resistant depression: methodological overview and operational criteria

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    63. Rybakowski, JK; Suwalska, A; Chlopocka-Wozniak, M
      Potentiation of antidepressants with lithium or carbamazepine in treatment-resistant depression

      NEUROPSYCHOBIOLOGY
    64. Benedetti, F; Colombo, C; Barbini, B; Campori, E; Smeraldi, E
      Ongoing lithium treatment prevents relapse after total sleep deprivation

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    65. Shergill, SS; Robertson, MM; Stein, G; Bernadt, M; Katona, CLE
      Outcome in refractory depression

      JOURNAL OF AFFECTIVE DISORDERS
    66. Shelton, RC
      Treatment options for refractory depression

      JOURNAL OF CLINICAL PSYCHIATRY
    67. Renaud, J; Axelson, D; Birmaher, B
      A risk-benefit assessment of pharmacotherapies for clinical depression in children and adolescents

      DRUG SAFETY
    68. Levine, J; Mishori, A; Susnosky, M; Martin, M; Belmaker, RH
      Combination of inositol and serotonin reuptake inhibitors in the treatmentof depression

      BIOLOGICAL PSYCHIATRY
    69. Rudas, S; Schmitz, M; Pichler, P; Baumgartner, A
      Treatment of refractory chronic depression and dysthymia with high-dose thyroxine

      BIOLOGICAL PSYCHIATRY
    70. Bech, P; Olsen, LR; Jarlov, N; Hammer, M; Schutze, T; Breum, L
      A case of sequential anti-stress medication in a patient with major depression resistant to amine-reuptake inhibitors

      ACTA PSYCHIATRICA SCANDINAVICA
    71. HEISER JF; WILCOX CS
      SEROTONIN 5-HT1A RECEPTOR AGONISTS AS ANTIDEPRESSANTS - PHARMACOLOGY RATIONALE AND EVIDENCE FOR EFFICACY

      CNS drugs
    72. ABOUSALEH MT
      PHARMACOLOGICAL TREATMENT OF MOOD DISORDERS IN THE ELDERLY

      Current opinion in psychiatry
    73. BAUER M; HELLWEG R; GRAF KJ; BAUMGARTNER A
      TREATMENT OF REFRACTORY DEPRESSION WITH HIGH-DOSE THYROXINE

      Neuropsychopharmacology
    74. BIRMAHER B; BRENT D; BERNET W; DUNNE JE; ADAIR M; ARNOLD V; BENSON RS; BUKSTEIN O; KINLAN J; MCCLELLAN J; RUE D
      PRACTICE PARAMETERS FOR THE ASSESSMENT AND TREATMENT OF CHILDREN AND ADOLESCENTS WITH DEPRESSIVE-DISORDERS

      Journal of the American Academy of Child and Adolescent Psychiatry
    75. ADLI M; BSCHOR T; CANATA B; DOPFMER S; BAUER M
      LITHIUM IN THE TREATMENT OF ACUTE DEPRESSION

      Fortschritte der Neurologie, Psychiatrie
    76. KOTLER M; MATAR MA
      LAMOTRIGINE IN THE TREATMENT OF RESISTANT BIPOLAR DISORDER

      Clinical neuropharmacology
    77. GAVRILOV V; LEVINE J; AGAM G; BELMAKER RH
      LITHIUM ENHANCEMENT OF THE PROLACTIN RESPONSE TO 5-HYDROXYTRYPTOPHAN IS NOT REVERSIBLE BY INOSITOL

      Progress in neuro-psychopharmacology & biological psychiatry
    78. CAPPIELLO A; MCDOUGLE CJ; DELGADO PL; MALISON RT; JATLOW P; CHARNEY DS; HENINGER GR; PRICE LH
      LITHIUM AND DESIPRAMINE VERSUS DESIPRAMINE ALONE IN THE TREATMENT OF SEVERE MAJOR DEPRESSION - A PRELIMINARY-STUDY

      International clinical psychopharmacology
    79. SOUERY D; MENDLEWICZ J
      COMPLIANCE AND THERAPEUTIC ISSUES IN RESISTANT DEPRESSION

      International clinical psychopharmacology
    80. JIMENEZ A; HEINZE G; AMARELLE A
      ELECTROCONVULSIVE TREATMENT IN RESISTANT MAJOR DEPRESSIVE PATIENTS

      Salud mental
    81. BYRNE SE; ROTHSCHILD AJ
      LOSS OF ANTIDEPRESSANT EFFICACY DURING MAINTENANCE THERAPY - POSSIBLEMECHANISMS AND TREATMENTS

      The Journal of clinical psychiatry
    82. HEIT S; NEMEROFF CB
      LITHIUM AUGMENTATION OF ANTIDEPRESSANTS IN TREATMENT-REFRACTORY DEPRESSION

      The Journal of clinical psychiatry
    83. THASE ME; HOWLAND RH; FRIEDMAN ES
      TREATING ANTIDEPRESSANT NONRESPONDERS WITH AUGMENTATION STRATEGIES - AN OVERVIEW

      The Journal of clinical psychiatry
    84. ROUILLON F; GORWOOD P
      THE USE OF LITHIUM TO AUGMENT ANTIDEPRESSANT MEDICATION

      The Journal of clinical psychiatry
    85. NELSON JC
      TREATMENT OF ANTIDEPRESSANT NONRESPONDERS - AUGMENTATION OR SWITCH

      The Journal of clinical psychiatry
    86. Bruijn, JA; Moleman, P; Mulder, PGH; van den Broek, WW
      Comparison of 2 treatment strategies for depressed inpatients: Imipramine and lithium addition or mirtazapine and lithium addition

      JOURNAL OF CLINICAL PSYCHIATRY
    87. NELSON JC
      COMBINED DRUG-TREATMENT STRATEGIES FOR MAJOR DEPRESSION

      Psychiatric annals
    88. ANANTH J
      TREATMENT-RESISTANT DEPRESSION

      Psychotherapy and psychosomatics
    89. WETTERLING T; MICHELS R; DILLING H
      ELECTROCONVULSIVE-THERAPY IN THERAPY-RESISTANT DEPRESSION IN OLD-AGE

      Nervenarzt
    90. BAUER M; HELLWEG R; BAUMGARTNER A
      HIGH-DOSE THYROXINE IN PATIENTS WITH THERAPY-RESISTANT AND PROPHYLAXIS-RESISTANT AFFECTIVE-DISORDERS

      Nervenarzt
    91. RUETER LE; KASAMO K; DEMONTIGNY C; BLIER P
      EFFECT OF LONG-TERM ADMINISTRATION OF DULOXETINE ON THE FUNCTION OF SEROTONIN AND NORADRENALINE TERMINALS IN THE RAT-BRAIN

      Naunyn-Schmiedeberg's archives of pharmacology
    92. RUETER LE; DEMONTIGNY C; BLIER P
      ELECTROPHYSIOLOGICAL CHARACTERIZATION OF THE EFFECT OF LONG-TERM DULOXETINE ADMINISTRATION ON THE RAT SEROTONERGIC AND NORADRENERGIC SYSTEMS

      The Journal of pharmacology and experimental therapeutics
    93. BEIQUE JC; DEMONTIGNY C; BLIER P; DEBONNEL G
      BLOCKADE OF 5-HYDROXYTRYPTAMINE AND NORADRENALINE UPTAKE BY VENLAFAXINE - A COMPARATIVE-STUDY WITH PAROXETINE AND DESIPRAMINE

      British Journal of Pharmacology
    94. POST RM; WEISS SRB
      SENSITIZATION AND KINDLING PHENOMENA IN MOOD, ANXIETY, AND OBSESSIVE-COMPULSIVE DISORDERS - THE ROLE OF SEROTONERGIC MECHANISMS IN ILLNESS PROGRESSION

      Biological psychiatry
    95. Bernadt, M
      Drug treatment of depression

      SEMINARS IN GENERAL ADULT PSYCHIATRY, VOLUMES 1-2
    96. POST RM; DENICOFF KD; LEVERICH GS; FRYE MA
      DRUG-INDUCED SWITCHING IN BIPOLAR DISORDER - EPIDEMIOLOGY AND THERAPEUTIC IMPLICATIONS

      CNS DRUGS
    97. LASSER RA; BALDESSARINI RJ
      THYROID-HORMONES IN DEPRESSIVE-DISORDERS - A REAPPRAISAL OF CLINICAL UTILITY

      Harvard review of psychiatry
    98. HORNIG M; MOZLEY PD; AMSTERDAM JD
      HMPAO SPECT BRAIN IMAGING IN TREATMENT-RESISTANT DEPRESSION

      Progress in neuro-psychopharmacology & biological psychiatry
    99. LANE R; BALDWIN D
      SELECTIVE SEROTONIN REUPTAKE INHIBITOR-INDUCED SEROTONIN SYNDROME - REVIEW

      Journal of clinical psychopharmacology
    100. BLOCH M; SCHWARTZMAN Y; BONNE O; LERER B
      CONCURRENT TREATMENT OF NONRESISTANT MAJOR DEPRESSION WITH DESIPRAMINE AND LITHIUM - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

      Journal of clinical psychopharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/02/20 alle ore 11:44:56